MCID: HSH003
MIFTS: 61

Hashimoto Thyroiditis malady

Categories: Genetic diseases, Rare diseases, Endocrine diseases, Immune diseases

Aliases & Classifications for Hashimoto Thyroiditis

About this section

Aliases & Descriptions for Hashimoto Thyroiditis:

Name: Hashimoto Thyroiditis 52 11 25 12
Autoimmune Thyroiditis 11 48 25 13 68
Chronic Lymphocytic Thyroiditis 11 48 25
Hashimoto's Thyroiditis 11 27 13
Hashimoto's Disease 11 48 25
Lymphocytic Thyroiditis 11 25
Hashimoto's Syndrome 11 48
Hashimoto Disease 25 68
Autoimmune Chronic Lymphocytic Thyroiditis 25
 
Chronic Lymphocytic Thyroiditides 25
Thyroiditis, Autoimmune 39
Hashimotos Thyroiditis 50
Thyroiditis, Chronic 48
Thyroiditis Chronic 50
Hashimoto's Struma 48
Hashimoto Syndrome 25
Hashimoto Struma 25

Characteristics:

HPO:

64
hashimoto thyroiditis:
Inheritance: autosomal dominant inheritance

Classifications:



External Ids:

OMIM52 140300
Disease Ontology11 DOID:7188
ICD1030 E06.3, E06.2
MeSH39 D013967
NCIt45 C38766

Summaries for Hashimoto Thyroiditis

About this section
NIH Rare Diseases:48 Hashimoto’s syndrome is a form of chronic inflammation that can damage the thyroid, reducing its ability to produce hormones (hypothyroidism). An early sign of the condition may be enlargement of the thyroid (called a goiter), which can potentially interfere with breathing or swallowing. Other signs and symptoms may include tiredness, weight gain, thin and dry hair, joint or muscle pain, constipation, cold intolerance, and/or a slowed heart rate. Affected women may have irregular menstrual periods or difficulty becoming pregnant. Hashimoto’s syndrome is the most common cause of hypothyroidism in the United States. It is more common in women than in men, and it usually appears in mid-adulthood. The exact cause is unknown but it is thought to result from a combination of genetic and environmental factors. Treatment is not always needed, but may include taking synthetic thyroid hormone. Last updated: 6/30/2015

MalaCards based summary: Hashimoto Thyroiditis, also known as autoimmune thyroiditis, is related to rheumatoid arthritis and systemic lupus erythematosus, and has symptoms including hashimoto thyroiditis and autoimmune antibody positivity. An important gene associated with Hashimoto Thyroiditis is CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4), and among its related pathways are Hormone ligand-binding receptors and Thyroxine (Thyroid Hormone) Production. The drugs thyroid (usp) and triiodothyronine have been mentioned in the context of this disorder. Affiliated tissues include thyroid gl, thyroid and heart, and related mouse phenotypes are liver/biliary system and vision/eye.

Genetics Home Reference:25 Hashimoto thyroiditis is a condition that affects the function of the thyroid, which is a butterfly-shaped gland in the lower neck. The thyroid makes hormones that help regulate a wide variety of critical body functions. For example, thyroid hormones influence growth and development, body temperature, heart rate, menstrual cycles, and weight. Hashimoto thyroiditis is a form of chronic inflammation that can damage the thyroid, reducing its ability to produce hormones.

Disease Ontology:11 An autoimmune disease of endocrine system that involves inflammation located in thyroid gland caused by the immune system reacting against its own tissues.

Description from OMIM:52 140300

Related Diseases for Hashimoto Thyroiditis

About this section

Diseases related to Hashimoto Thyroiditis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 180)
idRelated DiseaseScoreTop Affiliating Genes
1rheumatoid arthritis29.5CTLA4, ICAM1, IFNG, IL4, PTPN22
2systemic lupus erythematosus28.8CD40, CTLA4, FAS, FASLG, ICAM1, IFNG
3subacute lymphocytic thyroiditis12.3
4autoimmune thyroid disease 311.1
5autoimmune disease 111.0
6autoimmune thyroid disease 211.0
7lymphomatous thyroiditis10.8
8iatrogenic or traumatic pituitary deficiency10.8TG, TPO
9ovarian endometrioid cystadenoma10.8TG, TPO
10deep angioma10.8CALCA, TG
11landau-kleffner syndrome10.8FASLG, IFNG
12acute thyroiditis10.8CALCA, TG
13rhabdomyosarcoma, embryonal, 210.8TG, TPO
14pleomorphic adenoma10.7CALCA, TG
15myoclonus epilepsy10.7IFNG, IL4
16hypothryoidism, congenital, nongoitrous 410.7TG, TPO, TSHB
17thyroid hormonogenesis defect i10.7RET, TG
18presbyopia10.7CTLA4, TG, TSHR
19myotubular myopathy with abnormal genital development10.7FAS, IL4
20crohn's disease of the esophagus10.7TG, TPO, TSHR
21hypertelorism, preauricular sinus, punctal pits, and deafness10.7TG, TPO, TSHR
22nodular goiter10.7CALCA, TG, TPO
23calpainopathy10.7CALCA, FAS
24peripheral scars of retina10.7ICAM1, TG, TPO
25eye accommodation disease10.7IFNG, IL4
26demyelinating polyneuropathy10.7RET, TG, TSHR
27malignant syringoma10.7RET, TG, TSHR
28pediatric systemic lupus erythematosus10.7FAS, FASLG
29benign mesothelioma10.7RET, TG, TSHR
30childhood choriocarcinoma of the testis10.7CTLA4, FAS, FASLG
31granulomatous gastritis10.7FAS, FASLG
32acute gonococcal salpingitis10.6CTLA4, IFNG, IL4
33thyroiditis10.6
34dementia - subcortical10.6FAS, ICAM1, IFNG
35bolivian hemorrhagic fever10.6FASLG, ICAM1, IFNG
36binocular vision disease10.6CTLA4, IFNG, IL4
37motor peripheral neuropathy10.6IFNG, IL4
38mixed endometrial stromal and smooth muscle tumor10.6CALCA, TG
39benign renovascular hypertension10.6CTLA4, ICAM1, IFNG
40keratosis10.6FASLG, ICAM1, IFNG
41primary bacterial infectious disease10.6TG, TPO, TSHB, TSHR
42nodular prostate10.6CALCA, TG, TPO, TSHB
43orofaciodigital syndrome iv10.6CTLA4, FAS, FASLG
44ileitis10.6ICAM1, IL4
45nut allergy10.6IFNG, IL4
46meninges hemangiopericytoma10.6ICAM1, IFNG, IL4
47malignant histiocytosis10.5ICAM1, IFNG, IL4
48buphthalmos10.5ICAM1, IFNG, IL4
49wissler's syndrome10.5ICAM1, IFNG, IL4
50acquired central diabetes insipidus10.5SLC26A4, TG, TSHR

Graphical network of the top 20 diseases related to Hashimoto Thyroiditis:



Diseases related to hashimoto thyroiditis

Symptoms & Phenotypes for Hashimoto Thyroiditis

About this section

Symptoms by clinical synopsis from OMIM:

140300

Clinical features from OMIM:

140300

Human phenotypes related to Hashimoto Thyroiditis:

 64
id Description HPO Frequency HPO Source Accession
1 hashimoto thyroiditis64 HP:0000872
2 autoimmune antibody positivity64 HP:0030057

MGI Mouse Phenotypes related to Hashimoto Thyroiditis according to GeneCards Suite gene sharing:

41 (show all 18)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.1AIRE, CTLA4, FAS, FASLG, IFNG, IL4
2MP:00053919.0AIRE, FAS, FASLG, ICAM1, IFNG, IL4
3MP:00053889.0AIRE, CTLA4, FAS, FASLG, IFNG, IL4
4MP:00107718.9CTLA4, FAS, FASLG, ICAM1, IFNG, IL4
5MP:00020068.7AIRE, FAS, FASLG, ICAM1, IFNG, KRT19
6MP:00028738.6AIRE, CD40, CTLA4, FAS, FASLG, IFNG
7MP:00053678.4CD40, FAS, FASLG, IFNG, IL4, LGALS3
8MP:00053858.4CTLA4, FAS, FASLG, ICAM1, IFNG, KRT19
9MP:00053908.3CD40, CTLA4, FAS, FASLG, IFNG, IL4
10MP:00053898.3AIRE, FAS, FASLG, IFNG, IL4, KRT19
11MP:00053788.0AIRE, FAS, ICAM1, IFNG, IL4, KRT19
12MP:00053877.9AIRE, CD40, CTLA4, FAS, FASLG, ICAM1
13MP:00107687.8AIRE, CTLA4, FAS, FASLG, ICAM1, IFNG
14MP:00053977.7AIRE, CD40, CTLA4, FAS, FASLG, ICAM1
15MP:00053817.7AIRE, CTLA4, FAS, FASLG, ICAM1, IFNG
16MP:00053797.5AIRE, CD40, CTLA4, FAS, FASLG, ICAM1
17MP:00036317.5AIRE, CD40, FAS, FASLG, ICAM1, IFNG
18MP:00053767.3AIRE, CD40, CTLA4, FAS, FASLG, ICAM1

Drugs & Therapeutics for Hashimoto Thyroiditis

About this section

Drugs for Hashimoto Thyroiditis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 146)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Glatiramer Acetateapproved, investigationalPhase 493147245-92-93081884
Synonyms:
(2S)-2,6-diaminohexanoic acid
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-aminopentanedioic acid
(2S)-2-aminopropanoic acid
147245-92-9
AC1MIXQC
Aventis brand of copolymer 1
C089995
CID3081884
COP-1
Copaxone
Copolymer 1
 
Copolymer-1
Copoylmer 1
Glatiramer acetate
Glatiramer acetate [USAN]
L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
LS-186971
LS-71889
TV 5010
TV-5010
TV5010
Teva brand of copolymer 1
UNII-5M691HL4BO
acetic acid
2Trace ElementsPhase 4, Phase 25802
3AntioxidantsPhase 4, Phase 22928
4
SeleniumPhase 4, Phase 21757782-49-2
Synonyms:
Selanediide
Selenide
 
Selenide(2-)
Selenium
Selenium ion (Se2+)
5Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 110627
6Protective AgentsPhase 4, Phase 2, Phase 17190
7MicronutrientsPhase 4, Phase 25802
8Immunosuppressive AgentsPhase 4, Phase 3, Phase 212770
9Adjuvants, ImmunologicPhase 42484
10HematinicsPhase 41630
11Epoetin alfaPhase 4645113427-24-0
12methionineNutraceuticalPhase 480
13
Aripiprazoleapproved, investigationalPhase 3, Phase 1353129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify Discmelt
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
CPD000466383
 
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
14
Palivizumabapproved, investigationalPhase 325188039-54-5
Synonyms:
188039-54-5
D02737
Palivizumab
Palivizumab (INN)
 
Palivizumab (genetical recombination)
Palivizumab (genetical recombination) (JAN)
Synagis
Synagis (TN)
anti-RSV
15
Naltrexoneapproved, investigational, vet_approvedPhase 3, Phase 137816590-41-35360515
Synonyms:
16590-41-3
16676-29-2
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
BIDD:GT0405
BPBio1_000146
BRD-K88172511-310-03-8
BRN 3596648
BSPBio_000132
C07253
CCRIS 3506
CHEBI:121459
CHEBI:7465
CHEMBL142
CID5360515
Celupan
D05113
DB00704
Depade
EINECS 240-649-9
EN-1639A
HMS2089O11
HS-0002
HSDB 6750
LS-92094
MLS002153483
MolPort-004-920-221
 
MorViva
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Naltrexon
Naltrexona
Naltrexona [INN-Spanish]
Naltrexone
Naltrexone (USAN/INN)
Naltrexone Hcl
Naltrexone [USAN:BAN:INN]
Naltrexone [USAN:INN:BAN]
Naltrexone [Usan:Ban:Inn]
Naltrexonum
Naltrexonum [INN-Latin]
PDSP2_000847
PTI-555
Prestwick0_000116
Prestwick1_000116
Prestwick2_000116
Prestwick3_000116
ReVia
SMP1_000206
SPBio_002071
UM-792
UNII-5S6W795CQM
Vivitrex
Vivitrol
Vivitrol (TN)
naltrexone
naltrexone (ReVia)
16
Etanerceptapproved, investigationalPhase 3397185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
17
MethotrexateapprovedPhase 315181959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
18
DopamineapprovedPhase 3375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
19BrexpiprazoleapprovedPhase 334913611-97-9
20
AzithromycinapprovedPhase 333383905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
21
AdalimumabapprovedPhase 3, Phase 2478331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
22
EthanolapprovedPhase 3204364-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
23ImmunoglobulinsPhase 3, Phase 1, Phase 26045
24Anti-Infective AgentsPhase 3, Phase 2, Phase 121402
25AntibodiesPhase 3, Phase 1, Phase 26045
26AnalgesicsPhase 3, Phase 111287
27Anti-Inflammatory Agents, Non-SteroidalPhase 3, Phase 14295
28NarcoticsPhase 3, Phase 13486
29Narcotic AntagonistsPhase 3, Phase 1906
30
nalmefenePhase 3, Phase 12055096-26-95284594
Synonyms:
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinon-3,14-diol
(5alpha)-17-(cyclopropylmethyl)-6-methylidene-4,5-epoxymorphinan-3,14-diol
17-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol
55096-26-9
58895-64-0 (hydrochloride)
6-Desoxy-6-methylenenaltrexone
9a-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylen-3,14-morphinandiol
Alcofene
Arthene
C08027
CHEBI:200696
CHEMBL982
CID5284594
Cervene
Cessal
D05111
HSDB 6761
Incystene
JF 1
JF-1
LS-91713
 
MLS000069366
MolPort-003-959-014
N5770_SIGMA
NCGC00021666-03
NIH-10365
Nalmefene (USAN/INN)
Nalmefene [USAN:BAN:INN]
Nalmefeno
Nalmefeno [INN-Spanish]
Nalmefenum
Nalmefenum [INN-Latin]
Nalmetrene
Nalmetreno
Nalmetreno [INN-Spanish]
Nalmetrenum
Nalmetrenum [INN-Latin]
ORF 11676
ORF-11676
PDSP2_001543
Revex
SMR000058884
Soberal
UNII-TOV02TDP9I
nalmefene
31Peripheral Nervous System AgentsPhase 3, Phase 122776
32Gastrointestinal AgentsPhase 3, Phase 28109
33Analgesics, Non-NarcoticPhase 3, Phase 16260
34Neurotransmitter AgentsPhase 3, Phase 1, Phase 217734
35Serotonin AgentsPhase 33102
36Dopamine agonistsPhase 3618
37Dopamine AgentsPhase 33759
38Antibodies, MonoclonalPhase 33795
39Antipsychotic AgentsPhase 3, Phase 12359
40
SerotoninPhase 3356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
41Antiviral AgentsPhase 3, Phase 2, Phase 19732
42Anti-Inflammatory AgentsPhase 3, Phase 2, Phase 110355
43Psychotropic DrugsPhase 3, Phase 16279
44Tranquilizing AgentsPhase 3, Phase 14164
45Central Nervous System DepressantsPhase 3, Phase 112806
46
rituximabapprovedPhase 1, Phase 21654174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
47
GemcitabineapprovedPhase 2197495058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
48
Paclitaxelapproved, vet_approvedPhase 2275833069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nab-paclitaxel
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
49
ClarithromycinapprovedPhase 227181103-11-984029
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-Methylerythromycin
6-O-Methylerythromycin a
6-O-methyl erythromycin
81103-11-9
A-56268
AC-6813
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
BB_NC-1450
BIDD:GT0200
BSPBio_003453
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
Bio-0020
C06912
C2220
C30H54O11.C9H19NO2
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
CLARITHROMYCIN
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Clacine
Clambiotic
Claribid
Claricide
Clarith
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
 
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Cyllid
Cyllind
D00276
DRG-0099
DivK1c_006655
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
Helas
Heliclar
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
LMPK04000014
LS-1812
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
MLS000759516
MLS001201751
MLS001424066
Mabicrol
Macladin
Maclar
Mavid
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
NCGC00178054-01
NSC643733
Naxy
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SPECTRUM1504231
STK801952
SpecPlus_000559
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
Spectrum_000089
TE-031
TE031
UNII-H1250JIK0A
Veclam
Zeclar
clarithromycin
clarithromycina
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
50
Amoxicillinapproved, vet_approvedPhase 244126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin

Interventional clinical trials:

(show top 50)    (show all 77)
idNameStatusNCT IDPhase
1Selenium Supplementation in PregnancyUnknown statusNCT01465867Phase 4
2Post Partum Thyroiditis 2: Long Term ObservationsUnknown statusNCT00287144Phase 4
3Glatiramer Acetate for Multiple Sclerosis With Autoimmune ComorbiditiesCompletedNCT01456416Phase 4
4Selenium Supplementation in Youths With Autoimmune ThyroiditisRecruitingNCT02644707Phase 4
5Effect of Erythropoietin in Refractory Autoimmune Encephalitis PatientsRecruitingNCT03004209Phase 4
6Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive TherapyCompletedNCT02012218Phase 3
7Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety SymptomsCompletedNCT02013531Phase 3
8Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical ConditionsCompletedNCT01466062Phase 3
9Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work EnvironmentCompletedNCT02013609Phase 3
10Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute SchizophreniaCompletedNCT02054702Phase 3
11Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode SchizophreniaCompletedNCT02013622Phase 3
12Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00603993Phase 3
13Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid ArthritisCompletedNCT00690573Phase 3
14Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235872Phase 3
15A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00647491Phase 2, Phase 3
16A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial RhinosinusitisCompletedNCT00393835Phase 3
17Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)CompletedNCT02115750Phase 3
18Low Level Laser Therapy for Autoimmune ThyroiditisActive, not recruitingNCT02240563Phase 2, Phase 3
19A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)Active, not recruitingNCT02364947Phase 3
20Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and IrritabilityWithdrawnNCT02212613Phase 3
21Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AITUnknown statusNCT02302768Phase 2
22Low-Level Laser Therapy in Chronic Autoimmune ThyroiditisCompletedNCT01129492Phase 2
23Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)CompletedNCT01551498Phase 2
24An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With SchizophreniaCompletedNCT01716858Phase 2
25Adalimumab in Adult Japanese Subjects With Rheumatoid ArthritisCompletedNCT00235833Phase 2
26A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck CancerCompletedNCT02085460Phase 2
27Rituximab in IgG4-related Disease: A Phase 1-2 TrialCompletedNCT01584388Phase 1, Phase 2
28Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled TrialRecruitingNCT01896388Phase 1, Phase 2
29Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled TrialRecruitingNCT02305134Phase 1, Phase 2
30Study of NAC of GA Therapy for Patients With BRPCRecruitingNCT02926183Phase 2
31A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid LeukemiaActive, not recruitingNCT01961882Phase 2
32IL-2 in Refractory Autoimmune EncephalitisNot yet recruitingNCT02714959Phase 1, Phase 2
33Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. PyloriNot yet recruitingNCT02761005Phase 2
34Infections and Autoimmunity: Autobodies Screening in Multiple SclerosisUnknown statusNCT00230204Phase 1
35A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy SubjectsCompletedNCT01581463Phase 1
36A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal CancerCompletedNCT01801930Phase 1
37A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With SchizophreniaCompletedNCT02220712Phase 1
38A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male SubjectsCompletedNCT02679469Phase 1
39Phase 1 Study of SGI-110 in Patients With Acute Myeloid LeukemiaRecruitingNCT02293993Phase 1
40Pharmacodynamic Study of Cilostazol in Healthy VolunteersRecruitingNCT02554721Phase 1
41Hashimoto - a Surgical Disease. Absolute Total Thyroidectomy Makes Antibodies Disappear and Ameliorates SymptomsUnknown statusNCT02319538
42The Effect of Plaquenil on Serum Inflammatory Markers and Goiter in Euthyroid Young Women With Hashimoto's ThyroiditisUnknown statusNCT02126683
43CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual AbortionsUnknown statusNCT01644318
44Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto DiseaseCompletedNCT01102205
45Fetuin A in Hashimoto ThyroiditisCompletedNCT01884649
46Isolated ACTH Deficiency in Patients With Hashimoto ThyroiditisCompletedNCT00552487
47Hashimotos Thyroiditis and Thyroid CancerCompletedNCT01428167
48Oxidative Status in Children With Autoimmune ThyroiditisCompletedNCT02318160
49The Effect of Hydroxychloroquine Treatment in Hashimoto's ThyroiditisCompletedNCT01760421
50Selenium Treatment in Autoimmune Thyroiditis (AIT)CompletedNCT00271427

Search NIH Clinical Center for Hashimoto Thyroiditis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: thyroiditis, autoimmune

Genetic Tests for Hashimoto Thyroiditis

About this section

Genetic tests related to Hashimoto Thyroiditis:

id Genetic test Affiliating Genes
1 Hashimoto Thyroiditis27

Anatomical Context for Hashimoto Thyroiditis

About this section

MalaCards organs/tissues related to Hashimoto Thyroiditis:

36
Thyroid, Heart, Myeloid, Tonsil, Testes, Pituitary, B cells

FMA organs/tissues related to Hashimoto Thyroiditis:

17
Thyroid gl

Publications for Hashimoto Thyroiditis

About this section

Articles related to Hashimoto Thyroiditis:

(show top 50)    (show all 120)
idTitleAuthorsYear
1
Myxedema Psychosis in a Patient With Undiagnosed Hashimoto Thyroiditis. (28055088)
2017
2
Diagnostic difficulties by the unusual presentations in children and adolescents with Hashimoto thyroiditis. (27777910)
2016
3
Risk of Depression, Chronic Morbidities, and l-Thyroxine Treatment in Hashimoto Thyroiditis in Taiwan: A Nationwide Cohort Study. (26871858)
2016
4
Diagnostic value of Tg and TgAb for metastasis following ablation in patients with differentiated thyroid carcinoma coexistent with Hashimoto thyroiditis. (27158852)
2016
5
Letter to the Editor: Comment on "Thyroid stimulating antibodies are highly prevalent in Hashimoto thyroiditis and associated orbitopathy" Dear Editor. (27255721)
2016
6
Helicobacter pylori infection in women with Hashimoto thyroiditis: A case-control study. (27442635)
2016
7
An Adolescent Boy with Comorbid Anorexia Nervosa and Hashimoto Thyroiditis. (26757948)
2016
8
Assessment of ovarian reserve in euthyroid adolescents with Hashimoto thyroiditis. (26608409)
2016
9
Co-Existence of Thyroid Nodule and Thyroid Cancer in Children and Adolescents with Hashimoto Thyroiditis: A Single-Center Study. (26910846)
2016
10
Elevated interleukin-1I^ in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis. (26864865)
2016
11
Potential Influence of Selenium, Copper, Zinc and Cadmium on L-Thyroxine Substitution in Patients with Hashimoto Thyroiditis and Hypothyroidism. (27793066)
2016
12
RANKL/Osteoprotegerin System and Bone Turnover in Hashimoto Thyroiditis. (27328677)
2016
13
Hashimoto Thyroiditis and Nephrocalcinosis in a Child with Down Syndrome. (27147809)
2016
14
Sonographic Features of Nodular Hashimoto Thyroiditis. (27556192)
2016
15
Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation. (26791860)
2016
16
The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study. (26871795)
2016
17
Using Hashimoto thyroiditis as gold standard to determine the upper limit value of thyroid stimulating hormone in a Chinese cohort. (27816062)
2016
18
Excess iodine promotes apoptosis of thyroid follicular epithelial cells by inducing autophagy suppression and is associated with Hashimoto thyroiditis disease. (27448770)
2016
19
Hashimoto thyroiditis with an unusual presentation of cardiac tamponade in Noonan syndrome. (28018461)
2016
20
The Evolution of Thyroid Function after Presenting with Hashimoto Thyroiditis Is Different between Initially Euthyroid Girls with and Those without Turner Syndrome. (27866202)
2016
21
Celiac disease in children and adolescents with Hashimoto Thyroiditis. (27489467)
2016
22
Mulberry cells in the thyroid: warthin-finkeldey-like cells in hashimoto thyroiditis-associated lymphoma. (28024116)
2016
23
HASHIMOTO THYROIDITIS NOT ASSOCIATED WITH VITAMIN D DEFICIENCY. (27018618)
2016
24
HURTLE CELLS IMMUNOHISTOCHEMICAL ACTIVITIES IN HASHIMOTO THYROIDITIS PARENCHYMA. (28009314)
2016
25
Sonographic appearance of thyroid cancer in patients with Hashimoto thyroiditis. (25792586)
2015
26
Efficacy of a food supplement in patients with hashimoto thyroiditis. (25864745)
2015
27
Deficiency of respiratory chain complex I in Hashimoto thyroiditis. (26554844)
2015
28
Using Acoustic Structure Quantification During B-Mode Sonography for Evaluation of Hashimoto Thyroiditis. (26543169)
2015
29
Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis. (26211532)
2015
30
The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study. (26554782)
2015
31
Is diffusion-weighted imaging useful for differentiation between Graves' disease and Hashimoto thyroiditis? (26744855)
2015
32
The possible role of CD4(+)CD25 (high)Foxp3 (+)/CD4 (+)IL-17A (+) cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. (25771887)
2015
33
The role of diffusion weighted MR imaging for differentiation between Graves' disease and Hashimoto thyroiditis. (26241532)
2015
34
The effect of Hashimoto thyroiditis to low-dose (1,100 MBq) radioactive-iodine remnant ablation. (25899980)
2015
35
PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis. (26475096)
2015
36
The reliability of fine-needle aspiration biopsy in terms of malignancy in patients with hashimoto thyroiditis. (25692426)
2015
37
Levothyroxine Treatment of Euthyroid Children with Autoimmune Hashimoto Thyroiditis: Results of a Multicenter, Randomized, Controlled Trial. (26279111)
2015
38
Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis. (25971541)
2015
39
Overlapping Morphologic and Immunohistochemical Features of Hashimoto Thyroiditis and IgG4-Related Thyroid Disease. (25898816)
2015
40
Quality of life improvement in patients with Hashimoto thyroiditis and other goiters after surgery: A prospective cohort study. (26254997)
2015
41
Hashimoto thyroiditis onset after laparoscopic removal of struma ovarii: an overview to unravel a rare and intriguing finding. (26524822)
2015
42
Diagnostic value of strain ratio measurement in differential diagnosis of thyroid nodules coexisted with Hashimoto thyroiditis. (26131268)
2015
43
The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis. (26064115)
2015
44
Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? (25312294)
2014
45
Prurigo nodularis and Hashimoto thyroiditis. (25446192)
2014
46
Hashimoto thyroiditis: Clinical and diagnostic criteria. (24434360)
2014
47
Fine needle cytology and flow cytometry in hashimoto thyroiditis and primary thyroid lymphoma. (24642841)
2014
48
Recurrent spontaneous abortions, Hashimoto thyroiditis and alopecia totalis: response to anticoagulation and intravenous immunoglobulin therapy. (24308767)
2014
49
Melkersson-rosenthal syndrome with hashimoto thyroiditis in a 9-year-old girl: an autoimmune disorder. (24656464)
2014
50
Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population. (24703107)
2014

Variations for Hashimoto Thyroiditis

About this section

Expression for genes affiliated with Hashimoto Thyroiditis

About this section
Search GEO for disease gene expression data for Hashimoto Thyroiditis.

Pathways for genes affiliated with Hashimoto Thyroiditis

About this section

Pathways related to Hashimoto Thyroiditis according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathwaysScoreTop Affiliating Genes
110.1TSHB, TSHR
210.0TG, TPO, TSHR
39.9CALCA, FASLG, IFNG
49.9CTLA4, ICAM1, IFNG
5
Show member pathways
9.9FAS, FASLG, IFNG
69.8FASLG, ICAM1, IFNG
79.8ICAM1, IFNG, IL4
89.7CD40, IFNG, IL4
99.7CD40, ICAM1, IFNG
10
Show member pathways
9.7CTLA4, FASLG, IFNG, IL4
11
Show member pathways
9.6FAS, FASLG, IFNG, IL4
129.6FAS, FASLG, ICAM1, IFNG
139.5ICAM1, IFNG, IL4, LGALS3
14
Show member pathways
9.5SLC26A4, TG, TPO, TSHB, TSHR
159.5CD40, CTLA4, ICAM1, IL4
16
Show member pathways
9.4FAS, FASLG, ICAM1, IFNG, IL4
17
Show member pathways
9.4FAS, FASLG, ICAM1, IFNG, IL4
189.1CTLA4, FAS, FASLG, IFNG, IL4, LGALS3
19
Show member pathways
8.2CD40, CTLA4, FAS, FASLG, ICAM1, IFNG

GO Terms for genes affiliated with Hashimoto Thyroiditis

About this section

Cellular components related to Hashimoto Thyroiditis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1membrane raftGO:004512110.4FAS, FASLG, ICAM1, RET
2cell surfaceGO:000998610.0CD40, FAS, FASLG, ICAM1, TPO, TSHR
3external side of plasma membraneGO:00098979.7CD40, CTLA4, FAS, FASLG, ICAM1, IFNG
4integral component of plasma membraneGO:00058879.3CD40, CTLA4, FAS, FASLG, ICAM1, RET
5extracellular spaceGO:00056159.1CALCA, CD40, FAS, FASLG, ICAM1, IFNG
6plasma membraneGO:00058867.7ATP5O, CD40, CTLA4, FAS, FASLG, ICAM1

Biological processes related to Hashimoto Thyroiditis according to GeneCards Suite gene sharing:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1hormone biosynthetic processGO:004244610.9TG, TPO
2activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathwayGO:009729610.8FAS, FASLG
3necroptotic signaling pathwayGO:009752710.8FAS, FASLG
4iodide transportGO:001570510.7SLC26A4, TG
5negative regulation of T cell activationGO:005086810.7IL4, PTPN22
6positive regulation of extrinsic apoptotic signaling pathway in absence of ligandGO:200124110.7FAS, RET
7positive regulation of chemokine biosynthetic processGO:004508010.7IFNG, IL4
8positive regulation of MHC class II biosynthetic processGO:004534810.7IFNG, IL4
9positive regulation of mononuclear cell migrationGO:007167710.7IL4, LGALS3
10positive regulation of endothelial cell apoptotic processGO:200035310.7CD40, FASLG
11negative thymic T cell selectionGO:004506010.7AIRE, FAS
12positive regulation of tyrosine phosphorylation of Stat1 proteinGO:004251110.7CD40, IFNG
13extrinsic apoptotic signaling pathwayGO:009719110.6FAS, FASLG, IFNG
14inflammatory cell apoptotic processGO:000692510.6FAS, FASLG, IFNG
15regulation of extrinsic apoptotic signaling pathway via death domain receptorsGO:190204110.5FAS, FASLG, LGALS3
16negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGO:190204210.5FAS, FASLG, ICAM1
17apoptotic signaling pathwayGO:009719010.5CD40, FAS, FASLG
18defense response to protozoanGO:004283210.5CD40, IFNG, IL4
19positive regulation of isotype switching to IgG isotypesGO:004830410.4CD40, IFNG, IL4
20thyroid hormone generationGO:000659010.2TG, TPO
21regulation of immune responseGO:005077610.1CD40, ICAM1, IFNG, IL4
22response to drugGO:00424939.9FAS, ICAM1, IFNG, IL4, RET
23immune responseGO:00069559.8AIRE, CD40, CTLA4, FAS, FASLG, IL4
24response to lipopolysaccharideGO:00324969.4CD40, FAS, FASLG, ICAM1, PTPN22, TG

Molecular functions related to Hashimoto Thyroiditis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1hormone activityGO:000517910.6CALCA, TG, TSHB
2protein complex bindingGO:003240310.1FAS, ICAM1, KRT19, TG
3receptor activityGO:00048729.5CD40, FAS, ICAM1, RET

Sources for Hashimoto Thyroiditis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet